These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26118939)

  • 1. Position Statement on the management of continuous subcutaneous insulin infusion (CSII): The Italian Lazio experience.
    Maurizi AR; Suraci C; Pitocco D; Schiaffini R; Tubili C; Morviducci L; Giordano R; Manfrini S; Lauro D; Frontoni S; Pozzilli P; Buzzetti R;
    J Diabetes; 2016 Jan; 8(1):41-4. PubMed ID: 26118939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous subcutaneous insulin infusion in Italy: third national survey.
    Bruttomesso D; Laviola L; Lepore G; Bonfanti R; Bozzetto L; Corsi A; Di Blasi V; Girelli A; Grassi G; Iafusco D; Rabbone I; Schiaffini R;
    Diabetes Technol Ther; 2015 Feb; 17(2):96-104. PubMed ID: 25479035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps.
    Potti LG; Haines ST
    J Am Pharm Assoc (2003); 2009; 49(1):e1-13; quiz e14-7. PubMed ID: 19196588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.
    Roze S; Smith-Palmer J; Valentine WJ; Cook M; Jethwa M; de Portu S; Pickup JC
    J Med Econ; 2016; 19(3):236-42. PubMed ID: 26510389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An observational 7-year study of continuous subcutaneous insulin infusion for the treatment of type 1 diabetes mellitus.
    Papargyri P; Ojeda Rodríguez S; Corrales Hernández JJ; Mories Álvarez MT; Recio Córdova JM; Delgado Gómez M; Sánchez Marcos AI; Iglesias López RA; Herrero Ruiz A; Beaulieu Oriol M; Miralles García JM
    Endocrinol Nutr; 2014 Mar; 61(3):141-6. PubMed ID: 24355548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experiences of continuous subcutaneous insulin infusion in pregnant women with type 1 diabetes during delivery from four Italian centers: a retrospective observational study.
    Fresa R; Visalli N; Di Blasi V; Cavallaro V; Ansaldi E; Trifoglio O; Abbruzzese S; Bongiovanni M; Agrusta M; Napoli A
    Diabetes Technol Ther; 2013 Apr; 15(4):328-34. PubMed ID: 23537417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous subcutaneous insulin infusion preserves axonal function in type 1 diabetes mellitus.
    Kwai N; Arnold R; Poynten AM; Lin CS; Kiernan MC; Krishnan AV
    Diabetes Metab Res Rev; 2015 Feb; 31(2):175-82. PubMed ID: 25066412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
    Jarosz-Chobot P
    Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Position statement: Continuous subcutaneous insulin infusion in very young children with type 1 diabetes.
    Eugster EA; Francis G;
    Pediatrics; 2006 Oct; 118(4):e1244-9. PubMed ID: 17015512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing insulin pump therapy: the potential advantages of using a structured diabetes management program.
    Lange K; Ziegler R; Neu A; Reinehr T; Daab I; Walz M; Maraun M; Schnell O; Kulzer B; Reichel A; Heinemann L; Parkin CG; Haak T
    Curr Med Res Opin; 2015 Mar; 31(3):477-85. PubMed ID: 25597225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSII as an Alternative Therapeutic Strategy for Managing Type 2 Diabetes: Adding the Indian Experience to a Global Perspective.
    Kesavadev J; Shankar A; Sadasrian Pillai PB; Saboo B; Joshi S; Krishnan G; Jothydev S
    Curr Diabetes Rev; 2016; 12(4):312-314. PubMed ID: 26643928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes mellitus].
    Hasselmann C; Bonnemaison E; Faure N; Mercat I; Bouillo Pépin-Donat M; Magontier N; Chantepie A; Labarthe F
    Arch Pediatr; 2012 Jun; 19(6):593-8. PubMed ID: 22584198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Consensus document on continuous subcutaneous insulin infusion (CSII) treatment in paediatrics with type I diabetes].
    Barrio Castellanos R; García Cuartero B; Gómez Gila A; González Casado I; Hermoso López F; Luzuriaga Tomás C; Oyarzabal Irigoyen M; Rica Etxebarria I; Rodríguez Rigual M; Torres Lacruz M;
    An Pediatr (Barc); 2010 May; 72(5):352.e1-4. PubMed ID: 20409767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
    Sulli N; Shashaj B
    Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [From insulin pump and continuous glucose monitoring to the artificial pancreas].
    Apablaza P; Soto N; Codner E
    Rev Med Chil; 2017 May; 145(5):630-640. PubMed ID: 28898340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy.
    Bruttomesso D; Costa S; Baritussio A
    Diabetes Metab Res Rev; 2009 Feb; 25(2):99-111. PubMed ID: 19172576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consensus Statement on Use of Continuous Subcutaneous Insulin Infusion Therapy in the Hospital.
    Thompson B; Korytkowski M; Klonoff DC; Cook CB
    J Diabetes Sci Technol; 2018 Jul; 12(4):880-889. PubMed ID: 29681173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of infusion rate and indwelling time on tissue resistance pressure in small-volume subcutaneous infusion like in continuous subcutaneous insulin infusion.
    Patte C; Pleus S; Wiegel C; Schiltges G; Jendrike N; Haug C; Freckmann G
    Diabetes Technol Ther; 2013 Apr; 15(4):289-94. PubMed ID: 23427865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New concepts in diabetes: how multihormonal regulation can improve glycemic control.
    Blonde L; Baker DE; Davis SN; Ratner RE
    J Manag Care Pharm; 2004 Dec; 10(6 Suppl B):S3-8; quiz S9, S11-2. PubMed ID: 23570175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.